Global Stock News

Sesen Bio’s stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment

Article feature image

Sesen Bio’s stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment

Shares of Sesen Bio Inc.
SESN,
-57.23%
was rocked for a more than 75.4% loss on massive volume in afternoon trading Friday, after the company focused on cancer treatments shocked investors by saying it received a Complete Response Letter (CRL) from the…

Click here to view the original article.

Share this article

Scroll to Top